Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07265193

The Workplace-Based Hypertension Management Program

This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Hypertension is a major public health issue worldwide, and workplace settings represent a critical intervention opportunity for middle-aged populations. Nudge theory provides a cost-effective and behaviorally informed approach to promote sustainable health behaviors. This randomized controlled trial (RCT) will explore mechanisms of health behavior promotion, evaluate the effectiveness of a nudge-based workplace health management strategy, and contribute to evidence-based hypertension prevention and control in China.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18-60 years
  • Newly diagnosed hypertension (per 2024 Chinese hypertension guideline criteria)
  • Employed in Kailuan Group workplace settings
  • Able to provide informed consent

Exclusion criteria

  • Severe cardiovascular or renal disease at baseline
  • Psychiatric disorders affecting compliance
  • Pregnant or lactating women
  • Participation in other intervention trials

Treatment and study plan

Workplace-based Multicomponent Hypertension Management Program

Behavioral

Multicomponent strategies, including default scheduling of BP monitoring and counseling sessions, personalized reminders via workplace digital systems, social comparison feedback using anonymized peer data, small incentives and commitment devices.

Routine workplace health education and management according to current guidelines.

Other

Routine workplace health education and management according to current guidelines, including routine health education, standard hypertension counseling, and usual workplace health services.

Primary outcomes

  1. Change in systolic and diastolic blood pressure

    Time frame: up to 12 months

    Change in systolic and diastolic blood pressure from baseline to 12 months

Secondary outcomes

  1. Changes in hypertension-related health behaviors

    Time frame: up to 12 months

    Changes in hypertension-related health behaviors (dietary intake, physical activity, medication adherence) at 12 months

  2. Change in body mass index (BMI)

    Time frame: up to 12 months

    Change in body mass index (BMI) at 12 months

  3. Work productivity and quality of life scores

    Time frame: up to 12 months

    Work productivity and quality of life scores (e.g., the European Quality of Life-5 Dimensions) at 12 months

Sponsors and collaborators

Lead sponsor

Guangxi Medical University

Other

Registry information

Official study title

The Workplace-Based, Multicomponent Hypertension Management Program in Patients Aged 18-60 Years: A Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Dec 4, 2025
Registry last updated
Dec 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.